Stock listing

OTC:MYMX Mymetics Corp. Stock

Follow Mymetics Corp. into a list and get an email when it puts out news.

Share price · OTC:MYMX

$0.0003 USD 0.0000 (0.0%)

Close on Oct 14, 2026 · Data provided by Twelve Data

Ticker: OTC:MYMX
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: OTC
Currency: USD

Latest news

Mymetics and PCI Biotech Sign a Preclinical Research Collaboration

Aug 31, 2022

Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant

Nov 18, 2020

Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine

Nov 2, 2020

Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine

Sep 23, 2020

Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)

Jun 11, 2020

Mymetics Reports Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergy Immunotherapy

May 28, 2020

Mymetics starts Research Project in Cancer Immunotherapy with IO Biotech

May 25, 2020

Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines

May 18, 2020

Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine

Feb 4, 2020

Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes

Oct 17, 2019

All Mymetics Corp. news

Mymetics Corp. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 30 in all · newest Aug 31, 2022 · oldest 2014

Log in to ask 6ix AI your own questions about Mymetics Corp.